AstraZeneca Pharma India Ltd.

BSE: ASTRAZEN506820ISIN INE203A01020

Healthcare
Pharmaceuticals
BSE 1000

Share price

₹6,365.10+24.50 (+0.39%)

as of 4 Nov 2026

Prices adjusted for splits and bonuses; cash dividends excluded. Volume shows actual shares traded.

52W high: ₹9,833.90
52W low: ₹5,660.00
Off 52W high: -35.27%
1M return: +7.65%
3M return: -21.34%
6M return: -23.95%
1Y return: -33.61%
20D avg volume: 403
50 DMA: ₹6,453.89
200 DMA: ₹7,888.19

Key ratios Standalone

Market cap: ₹15,913 Cr
Current price: ₹6,365.10
52W high / low: ₹9,833.90 / ₹5,660.00
Face value: ₹2.00
P/E: 93.81
P/B: 23.42
EPS (TTM): ₹67.85
Book value / share: ₹271.78
ROE: 24.97%
ROCE: 25.50%
Operating margin: 8.48%
Net margin: 5.56%
Debt / equity: 0.00
Net debt: ₹-447.72 Cr
Interest cover: 57.17
Dividend yield: 0.57%
Dividend / share (TTM): ₹36.00
Payout: 53.06%
Cash conversion cycle: 73.6 days

Financials

Metric	Q1 FY27	Q4 FY26	Q3 FY26	Q2 FY26	Q1 FY26	Q4 FY25	Q3 FY25	Q2 FY25	Q1 FY25	Q4 FY24	Q3 FY24	Q2 FY24
Income statement
	682.79	578.61	611.57	559.09	526.31	480.48	440.29	408.00	387.52	383.20	305.79	311.07
	9.23	5.95	5.13	6.17	11.24	16.15	7.98	8.15	8.35	8.66	9.66	8.37
	692.02	584.56	616.70	565.26	537.55	496.63	448.27	416.15	395.87	391.86	315.45	319.44
	641.03	525.34	571.64	487.15	462.49	412.48	372.70	365.12	353.46	337.51	295.05	262.49
	0.00	0.00	0.00	0.00	9.49	94.25	69.88	77.14	45.85	33.62	37.52	38.80
	304.62	312.31	697.12	432.40	417.59	287.86	228.76	251.87	240.33	74.98	181.53	139.94
	79.16	45.70	93.78	60.45	64.45	66.07	62.37	68.04	60.96	57.98	63.23	65.27
	1.95	2.04	1.06	0.67	0.72	0.68	0.33	0.34	0.11	0.07	0.61	0.50
	5.23	5.60	3.84	2.57	16.57	17.69	9.07	9.31	3.91	3.76	3.70	3.67
	107.48	77.75	106.57	98.97	85.34	68.43	31.32	36.95	40.69	36.96	50.89	54.16
	50.99	59.22	45.06	78.11	75.06	84.15	75.57	51.03	42.41	54.35	20.40	56.96
	-0.24	-1.08	1.48	-5.29	-0.36	-5.68	-33.55	—	-57.56	—	—	16.43
	50.75	58.14	46.54	72.82	74.70	78.47	42.02	51.03	-15.16	54.35	20.40	73.38
	12.82	13.26	13.95	18.60	18.87	20.22	11.17	12.60	3.37	14.88	4.60	21.02
	37.93	44.88	32.59	54.22	55.83	58.25	30.85	38.43	-11.79	39.48	15.80	52.37
	15.17	17.95	13.04	21.69	22.33	23.30	12.34	15.37	-4.72	15.79	6.32	20.95
Key metrics
	57.93	65.78	51.44	76.06	91.99	96.84	51.42	60.68	-11.14	58.18	24.71	77.55
	8.50%	11.40%	8.40%	13.60%	17.50%	20.20%	11.70%	14.90%	-2.90%	15.20%	8.10%	24.90%
	5.60%	7.80%	5.30%	9.70%	10.60%	12.10%	7.00%	9.40%	-3.00%	10.30%	5.20%	16.80%
	—	6.00%	—	8.80%	—	9.70%	—	—	—	—	—	—
	29.70%	20.40%	38.90%	37.00%	35.80%	25.40%	44.00%	31.20%	—	—	—	—
	-32.10%	-23.00%	5.60%	41.10%	573.50%	47.50%	95.30%	-26.60%	—	—	—	—

Metric	TTM	FY26	FY25	FY24	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Income statement
	2,432	2,276	1,716	1,296	1,003	805.60	813.56	831.81	728.29	571.99	539.57
	26.48	28.49	40.63	34.80	26.10	14.76	12.84	12.99	16.29	12.25	19.64
	2,459	2,304	1,757	1,330	1,029	820.36	826.40	844.80	744.58	584.24	559.21
	2,225	2,047	1,504	1,127	854.74	737.32	699.31	730.84	671.92	540.44	526.01
	0.00	9.49	287.13	129.02	84.38	89.61	97.26	70.21	62.67	27.88	14.00
	1,746	1,859	1,009	499.31	324.46	207.88	—	274.23	169.84	204.21	142.16
	279.09	264.38	257.44	241.45	259.10	230.21	—	216.70	197.40	153.53	163.48
	5.72	4.49	1.46	1.20	0.63	0.95	1.09	1.14	—	—	—
	17.24	28.58	39.99	14.94	16.26	16.95	—	18.58	14.92	14.74	15.83
	390.77	368.63	241.87	183.62	157.35	122.54	115.68	131.84	148.66	117.28	118.98
	233.38	257.45	253.15	203.11	174.33	83.04	127.09	113.96	72.66	43.80	33.20
	-5.13	-5.25	-96.79	16.43	-40.23	—	—	—	—	—	—
	228.25	252.20	156.36	219.53	134.10	83.04	127.09	113.96	72.66	43.80	33.20
	58.63	64.68	40.62	58.03	34.81	21.44	33.79	41.75	18.22	17.89	8.76
	169.62	187.52	115.74	161.51	99.29	61.59	93.30	72.21	54.44	25.91	24.44
	67.85	75.01	46.30	64.60	39.72	24.64	37.32	28.88	21.78	—	—
Key metrics
	251.21	285.27	197.81	235.67	150.99	100.94	128.18	133.68	87.58	58.54	49.03
	10.33%	12.50%	11.50%	18.20%	15.10%	12.50%	15.80%	16.10%	12.00%	10.20%	9.10%
	6.97%	8.20%	6.70%	12.50%	9.90%	7.60%	11.50%	8.70%	7.50%	4.50%	4.50%
	—	25.50%	19.40%	—	—	—	—	—	—	—	—
	31.10%	32.60%	32.50%	29.20%	24.50%	-1.00%	-2.20%	14.20%	27.30%	6.00%	—
	-7.49%	62.00%	-28.30%	62.70%	61.20%	-34.00%	29.20%	32.60%	110.10%	6.00%	—
	—	-18.75	63.61	—	—	—	—	—	—	—	—
	—	-0.08	0.56	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	-447.72	-536.14	—	—	—	—	—	—	—	—
	—	73.6	58.9	—	—	—	—	—	—	—	—
Balance sheet
	—	1,989	1,518	—	—	—	—	—	—	—	—
	—	1,732	1,342	—	—	—	—	—	—	—	—
	—	447.72	536.14	—	—	—	—	—	—	—	—
	—	213.68	184.88	—	—	—	—	—	—	—	—
	—	1,027	548.50	—	—	—	—	—	—	—	—
	—	33.82	56.17	—	—	—	—	—	—	—	—
	—	117.47	63.58	—	—	—	—	—	—	—	—
	—	782.70	456.30	—	—	—	—	—	—	—	—
	—	981.81	703.00	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	0.00	0.00	—	—	—	—	—	—	—	—
	—	872.79	770.35	—	—	—	—	—	—	—	—
Cash flow
	—	-15.14	65.36	—	—	—	—	—	—	—	—
	—	18.69	30.80	—	—	—	—	—	—	—	—
	—	-91.97	-65.59	—	—	—	—	—	—	—	—
	—	3.61	1.75	—	—	—	—	—	—	—	—

Compounded growth

Sales CAGR 3Y: +31.40%
Sales CAGR 5Y: +22.84%
Profit CAGR 3Y: +23.61%
Profit CAGR 5Y: +14.98%
Sales YoY (TTM): +31.10%
Profit YoY (TTM): -7.49%

Compounded from reported annual figures. We publish no share-price CAGR: our prices are as-traded, so one would be wrong across every split and bonus issue.

Shareholding as of 30 Sep 2026

Promoter holding: 75.00%

Quarter	30 Sep 2026	September 2026	June 2026
Promoter %	75.00%	75.00%	75.00%

Holder	Type	Holding	Previous	Change
AstraZeneca Pharmaceuticals AB	Promoter	75.00%	75.00%	0.00%
NIPPON LIFE INDIA TRUSTEE LTD-A/C NIPPON INDIA SMALL CAP FUND(VARIOUS SCHEMES)	Public	2.90%	2.90%	0.00%
TEJAS BHALCHANDRA TRIVEDI	Public	2.30%	2.30%	0.00%
ICICI PRUDENTIAL - VARIOUS SCHEMES	Public	2.18%	2.18%	0.00%
SHIVANI T. TRIVEDI	Public	1.72%	1.72%	0.00%
BANDHAN - VARIOUS SCHEMES	Public	1.50%	1.50%	0.00%
PRASHANT JAIN	Public	1.10%	1.10%	0.00%
AstraZeneca AB	Promoter Group	0.00%	0.00%	0.00%

Public shareholders are disclosed individually only above 1%.

Peer comparison

Company	Mkt cap (₹ Cr)	Price (₹)	P/E	ROCE	Sales YoY	Profit YoY	1Y return
Sun Pharmaceutical Industries Ltd.	4,26,112	1,776.00	38.78	17.90%	+12.13% TTM	+4.79% TTM	+4.92%
Divi's Laboratories Ltd.	2,66,424	10,036.00	91.09	19.00%	+16.35% TTM	+26.84% TTM	+47.61%
Torrent Pharmaceuticals Ltd.	1,79,908	4,730.00	85.71	9.10%	+42.06% TTM	-1.92% TTM	+32.24%
Laurus Labs Limited	1,24,601	2,306.10	93.53	19.70%	+23.03% TTM	+95.38% TTM	+134.59%
Zydus Lifesciences Limited	1,18,703	1,190.00	25.85	19.20%	+21.11% TTM	-2.51% TTM	+22.32%
Dr. Reddy's Laboratories Ltd.	1,14,513	1,372.00	41.50	13.90%	-3.53% TTM	-51.90% TTM	+14.26%
Cipla Ltd.	1,13,110	1,400.10	39.63	14.90%	-0.74% TTM	-47.48% TTM	-6.88%
Mankind Pharma Limited	1,04,631	2,533.15	46.22	13.70%	+13.27% TTM	+27.60% TTM	+6.91%
Aurobindo Pharma Ltd.	97,878	1,701.10	26.38	13.60%	+9.09% TTM	+9.48% TTM	+47.79%
Lupin Ltd	92,145	2,015.00	17.65	28.40%	+24.22% TTM	+20.10% TTM	+0.84%
Glenmark Pharmaceuticals ltd	70,608	2,501.85	39.27	16.20%	+32.94% TTM	+138.48% TTM	+35.48%
Alkem Laboratories Limited	62,054	5,190.00	28.15	18.80%	+13.36% TTM	-5.52% TTM	-8.38%
Abbott India Ltd. S	57,685	27,146.85	35.73	41.90%	+6.29% TTM	+11.18% TTM	-7.56%
Biocon Ltd.	56,061	344.00	134.63	2.90%	+5.70% TTM	-55.37% TTM	-9.53%
Gland Pharma Limited	52,105	3,157.70	46.16	13.70%	+17.57% TTM	+46.55% TTM	+65.09%
Ipca Laboratories Ltd.	50,051	1,973.15	36.40	16.40%	+10.59% TTM	+67.91% TTM	+52.33%
GlaxoSmithkline Pharmaceuticals Ltd.	42,904	2,532.60	37.42	55.40%	+12.12% TTM	+20.03% TTM	-4.84%
Ajanta Pharma Ltd.	41,406	3,313.55	32.79	29.40%	+25.01% TTM	+29.70% TTM	+26.89%
Emcure Pharmaceuticals Limited	41,254	2,174.55	37.75	25.10%	+21.12% TTM	+33.34% TTM	+64.07%
J.B. Chemicals & Pharmaceuticals Lt	38,731	2,412.25	47.77	21.90%	+5.87% TTM	+7.56% TTM	+45.79%
Sai Life Sciences Limited	32,855	1,546.30	90.80	18.10%	—	—	+67.49%
PIRAMAL PHARMA LIMITED	31,659	237.80	-151.21	0.80%	+9.43% TTM	-781.93% TTM	+18.60%
ACUTAAS CHEMICALS LIMITED	30,928	3,777.65	70.51	27.70%	+45.18% TTM	+95.78% TTM	+106.30%
Wockhardt Ltd	30,869	1,899.80	76.22	6.40%	+25.70% TTM	+894.12% TTM	+39.18%
RUBICON RESEARCH LIMITED	28,416	1,716.55	98.59	24.30%	—	—	+164.06%
AstraZeneca Pharma India Ltd. S	15,913	6,365.10	93.81	25.50%	+31.10% TTM	-7.49% TTM	-33.61%

Filings & corporate actions

Recent announcements

Please find the enclosed intimation of the Company as per the captioned subject for your reference.2 Nov 2026 · Company Update / Award of Order / Receipt of Order
Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 05/11/2026 ,inter alia, to consider and approve the Un-audited Financial ....30 Oct 2026 · Board Meeting / Board Meeting
Please find the enclosed intimation of the Company as per the captioned subject for your reference.27 Oct 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find the enclosed Press Release as per the captioned subject for your reference.16 Oct 2026 · Company Update / Press Release / Media Release
Please find the enclosed letter of the Company as per the captioned subject for your reference.16 Oct 2026 · AGM/EGM / Postal Ballot
Please find the enclosed intimation of the Company as per the captioned subject for your reference.16 Oct 2026 · Company Update / Credit Rating
Please find the enclosed intimation of the Company with respect to the captioned subject for your reference.18 Sep 2026 · Company Update / Award of Order / Receipt of Order
Please find the enclosed intimation of the Company as per the captioned subject for your reference.15 Sep 2026 · Insider Trading / SAST / Closure of Trading Window
Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.15 Sep 2026 · Company Update / General
Please find the enclosed intimation of the Company as per the captioned subject for your reference.2 Sep 2026 · Company Update / General
Please find the enclosed document of the Company in relation to the captioned subject for your reference.25 Aug 2026 · Company Update / Award of Order / Receipt of Order
Please find the enclosed intimation of the Company in relation to the captioned subject for reference.24 Aug 2026 · Company Update / General
Please find the enclosed intimation of the Company in relation to the captioned subject for your reference.21 Aug 2026 · Company Update / Analyst / Investor Meet
Please find the enclosed intimation of the Company as per the captioned subject for your reference.15 Aug 2026 · Company Update / Analyst / Investor Meet
Please find the enclosed intimation of the Company as per the captioned subject for your reference.12 Aug 2026 · AGM/EGM / AGM
Please find the enclosed Press Release of the Company for your reference.11 Aug 2026 · Company Update / Press Release / Media Release
Please find the enclosed intimation of the Company as per the captioned subject for your reference.10 Aug 2026 · AGM/EGM / AGM
Please find the enclosed intimation of the Company as per the captioned subject for your reference.10 Aug 2026 · Result / Financial Results
Please find the enclosed letter of the Company as per the captioned subject for your reference.8 Aug 2026 · Company Update / General
Astrazeneca Pharma India Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 10/08/2026 ,inter alia, to consider and approve This is to inform ....4 Aug 2026 · Board Meeting / Board Meeting
Please find the enclosed document of the Company in relation to the captioned subject for your reference.30 Jul 2026 · Company Update / General
Please find the enclosed intimation of the Company as per the captioned subject for your reference.29 Jul 2026 · Company Update / Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find the enclosed intimation of the Company as per the captioned subject for your reference.28 Jul 2026 · Company Update / General
Please find the enclosed letter of the Company as per the captioned subject for your reference.28 Jul 2026 · Company Update / General
Please find the enclosed intimation of the Company as per the captioned subject for your reference.22 Jul 2026 · Company Update / General
Please find the enclosed intimation of the Company as per the captioned subject for your reference.21 Jul 2026 · Company Update / Resignation of Chief Financial Officer (CFO)
Please find the enclosed intimation of the Company as per the captioned subject for your reference.20 Jul 2026 · Company Update / Newspaper Publication
Please find the enclosed intimation of the Company as per the captioned subject for your reference.18 Jul 2026 · Corp. Action / Record Date
Please refer to the enclosed revised intimation as per the captioned subject due to inadvertent omission of certain pages of the assurance statement from the previous intimation.18 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Please find the enclosed document as per the captioned subject for reference.18 Jul 2026 · Others / Business Responsibility and Sustainability Reporting (BRSR)
Pursuant to Regulation 34(1) of the SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015 ('Listing Regulations'), please find enclosed the Annual Report of the Company ....18 Jul 2026 · Others / Reg. 34 (1) Annual Report
Please find the enclosed intimation of the Company as per the captioned subject for your reference.18 Jul 2026 · AGM/EGM / AGM
Please find the enclosed letter of the Company in relation to the captioned subject for your reference.16 Jul 2026 · Company Update / General
Please find the enclosed intimation of the Company as per the captioned subject for your reference.6 Jul 2026 · Company Update / General
Please find the enclosed letter of the Company as per the captioned subject for reference.16 Jun 2026 · Company Update / General
Please find the enclosed intimation of the Company as per the captioned subject for your reference.15 Jun 2026 · Insider Trading / SAST / Closure of Trading Window
Please find the enclosed intimation of the Company with respect to the captioned subject for your reference.12 Jun 2026 · Company Update / General
Please find the enclosed intimation of the Company as per the captioned subject for review.11 Jun 2026 · Company Update / General
Please find the enclosed intimation of the Company as per the captioned subject for your reference.4 Jun 2026 · Company Update / General
Please find the enclosed intimation of the Company as per the captioned subject for your reference.3 Jun 2026 · Company Update / General

Corporate actions

Purpose	Ex date	Record date	Payment date
Final Dividend - Rs. - 36.0000	31 Jul 2026	31 Jul 2026	—
Dividend - Rs. - 32.0000	18 Jul 2025	18 Jul 2025	—
Final Dividend - Rs. - 24.0000	5 Jul 2024	5 Jul 2024	—

Board meetings

5 Nov 2026 Board Meeting - Financial Results
10 Aug 2026 Board Meeting - Financial Results